doi: 10.1257/089533002320950975.
Pharmaceuticals in U.S. health care: determinants of quantity and price
Affiliations
- PMID: 15179978
- DOI: 10.1257/089533002320950975
Item in Clipboard
Pharmaceuticals in U.S. health care: determinants of quantity and price
J Econ Perspect.
2002 Fall.
No abstract available
Similar articles
-
Pharmaceutical expenditure in Sweden.Health Policy. 1999 May;47(2):125-44. doi: 10.1016/s0168-8510(99)00016-0. Health Policy. 1999. PMID: 10538288
-
Will lower drug prices jeopardize drug research? A policy fact sheet.Am J Bioeth. 2004 Winter;4(1):W1-4. doi: 10.1162/152651604773067488. Am J Bioeth. 2004. PMID: 15035915 No abstract available.
-
Increases in Drug Spending Slow.State Legis. 2017 Apr;43(4):6. State Legis. 2017. PMID: 28574682 No abstract available.
-
Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes.Pharmacoeconomics. 2002;20(9):577-91. doi: 10.2165/00019053-200220090-00002. Pharmacoeconomics. 2002. PMID: 12141886 Review.
-
Exploring the rise in American pharmaceutical prices.Pharos Alpha Omega Alpha Honor Med Soc. 2002 Spring;65(2):11-5. Pharos Alpha Omega Alpha Honor Med Soc. 2002. PMID: 12099112 Review. No abstract available.
Cited by
-
Market power and state costs of HIV/AIDS drugs.Int J Health Care Finance Econ. 2007 Mar;7(1):59-71. doi: 10.1007/s10754-007-9012-0. Epub 2007 May 5. Int J Health Care Finance Econ. 2007. PMID: 17484050
-
Pharmaceutical risk-sharing agreements.Pharmacoeconomics. 2008;26(7):551-6. doi: 10.2165/00019053-200826070-00002. Pharmacoeconomics. 2008. PMID: 18563946
-
Generic script share and the price of brand-name drugs: the role of consumer choice.Int J Health Care Finance Econ. 2009 Sep;9(3):291-316. doi: 10.1007/s10754-008-9052-0. Epub 2009 Jan 8. Int J Health Care Finance Econ. 2009. PMID: 19130220
-
Generic substitution: micro evidence from register data in Norway.Eur J Health Econ. 2011 Feb;12(1):49-59. doi: 10.1007/s10198-010-0226-6. Epub 2010 Mar 6. Eur J Health Econ. 2011. PMID: 20213182
-
The effect of pharmaceutical patent term length on research and development and drug expenditures in Canada.Healthc Policy. 2007 Feb;2(3):63-84. Healthc Policy. 2007. PMID: 19305720 Free PMC article.